Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating combination chemotherapy for metastatic carcinoma of unknown primary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Carcinoma of Unknown Primary | Phase 3 | Status: UNKNOWN